| Q104470666 | A diet rich in fruit and whole grains is associated with a low risk of type 2 diabetes mellitus: findings from a case-control study in South China |
| Q57108408 | Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence? |
| Q90737299 | An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics |
| Q26741423 | Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects |
| Q92717497 | Do Probiotics Improve the Health Status of Individuals with Diabetes Mellitus? A Review on Outcomes of Clinical Trials |
| Q90605713 | Effect of Bifidobacterium lactis HN019 on inflammatory markers and oxidative stress in subjects with and without the metabolic syndrome |
| Q48290607 | Effect of Probiotic Soy Milk on Serum Levels of Adiponectin, Inflammatory Mediators, Lipid Profile, and Fasting Blood Glucose Among Patients with Type II Diabetes Mellitus. |
| Q26745869 | Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials |
| Q40044003 | Effects of Probiotics, Prebiotics, and Synbiotics on Human Health |
| Q92858077 | Effects of probiotics on the lipid profile: systematic review |
| Q92735179 | Effects of probiotics on type II diabetes mellitus: a meta-analysis |
| Q100464250 | Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) |
| Q51143897 | Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease. |
| Q55605649 | Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions. |
| Q64099563 | Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials |
| Q51377185 | Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. |
| Q47692785 | Intake of Milk or Fermented Milk Combined With Fruit and Vegetable Consumption in Relation to Hip Fracture Rates: A Cohort Study of Swedish Women |
| Q47235131 | Microbial Regulation of Glucose Metabolism and Insulin Resistance |
| Q99414054 | Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes |
| Q33616944 | Mismatch between Probiotic Benefits in Trials versus Food Products |
| Q38754711 | Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes |
| Q92983650 | Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials |
| Q97548339 | Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials |
| Q93051780 | Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo |
| Q33810967 | Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics |
| Q64072092 | The Effect of Probiotic Yogurt on Glycemic Control in Type 2 Diabetes or Obesity: A Meta-Analysis of Nine Randomized Controlled Trials |
| Q92264899 | The Impact of Dairy Products in the Development of Type 2 Diabetes: Where Does the Evidence Stand in 2019? |
| Q38645113 | The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals |
| Q49557929 | The effects of probiotics on total cholesterol: A meta-analysis of randomized controlled trials |